Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-02-13 Sale |
2025-02-14 6:35 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
2,879 | $116.79 | $336,239 | 96,479 (Direct) |
View |
2025-01-31 Sale |
2025-02-04 5:51 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
126 | $152.97 | $19,274 | 15,799 (Direct) |
View |
2024-11-29 Sale |
2024-12-03 6:52 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
2,331 | $126.29 | $294,373 | 19,875 (Direct) |
View |
2024-02-13 Sale |
2024-02-15 5:48 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
1,432 | $132.94 | $190,371 | 77,957 (Direct) |
View |
2024-01-31 Sale |
2024-02-02 7:26 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
126 | $141.94 | $17,884 | 11,843 (Direct) |
View |
2023-11-29 Sale |
2023-12-01 5:41 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
2,331 | $113.57 | $264,733 | 11,732 (Direct) |
View |
2023-08-21 Sale |
2023-08-23 8:10 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
3,198 | $107.37 | $343,368 | 9,638 (Direct) |
View |
2023-02-07 Sale |
2023-02-08 7:38 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
4,508 | $102.3 | $461,166 | 6,525 (Direct) |
View |
2023-01-31 Sale |
2023-02-02 5:26 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
126 | $108.48 | $13,668 | 2,477 (Direct) |
View |
2022-11-29 Sale |
2022-12-01 6:35 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
2,331 | $121.9 | $284,160 | 2,366 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-12 Option Award |
2025-02-14 6:35 pm |
N/A 2035-02-12 |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
64,886 | $0 | 96,479 (Direct) |
View |
2025-02-13 Exercise |
2025-02-14 6:35 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
5,407 | $0 | 96,479 (Direct) |
View |
2025-01-31 Exercise |
2025-02-04 5:51 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
238 | $0 | 15,799 (Direct) |
View |
2024-11-29 Exercise |
2024-12-03 6:52 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
4,426 | $0 | 19,875 (Direct) |
View |
2024-06-05 Option Award |
2024-06-07 4:20 pm |
N/A 2034-06-05 |
Voyager Therapeutics Inc. | VYGR | Onyia Jude Director |
24,000 | $0 | 24,000 (Direct) |
View |
2024-02-13 Option Award |
2024-02-15 5:48 pm |
N/A 2034-02-13 |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
64,829 | $0 | 77,957 (Direct) |
View |
2023-06-06 Option Award |
2023-06-07 4:39 pm |
N/A 2033-06-06 |
Voyager Therapeutics Inc. | VYGR | Onyia Jude Director |
22,000 | $0 | 22,000 (Direct) |
View |
2023-02-23 Option Award |
2023-02-27 5:19 pm |
N/A 2033-02-23 |
Voyager Therapeutics Inc. | VYGR | Onyia Jude Director |
44,000 | $0 | 44,000 (Direct) |
View |
Ownership |
2023-02-27 5:16 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Onyia Jude Director |
0 | $0 | 2,910 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 7:14 pm |
N/A 2033-02-13 |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
78,409 | $0 | 78,409 (Direct) |
View |
2022-01-31 Option Award |
2022-02-02 7:58 pm |
N/A 2032-01-31 |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
7,414 | $0 | 7,414 (Direct) |
View |
2021-11-29 Option Award |
2021-12-01 8:02 pm |
N/A 2031-11-29 |
NEUROCRINE BIOSCIENCES INC | NBIX | Onyia Jude Chief Scientific Officer |
137,871 | $0 | 137,871 (Direct) |
View |